Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Carcinoma, Non-Small-Cell Lung 23Breast Neoplasms 22Colorectal Neoplasms 14Ovarian Neoplasms 12Lung Neoplasms 10Neoplasm Metastasis 9Stomach Neoplasms 8Neoplasms 8Nasopharyngeal Carcinoma 8Leukemia, Myeloid, Acute 7Triple Negative Breast Neoplasms 6Squamous Cell Carcinoma of Head and Neck 6Rectal Neoplasms 6Fallopian Tube Neoplasms 6Recurrence 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Esophageal Squamous Cell Carcinoma 5Uterine Cervical Neoplasms 4Prostatic Neoplasms 4Lymphoma, Non-Hodgkin 4Leukemia 4Head and Neck Neoplasms 4Esophageal Neoplasms 4Carcinoma, Ovarian Epithelial 4Pancreatic Neoplasms 3Neoplasms by Site 3Lymphoma, Large B-Cell, Diffuse 3Adenocarcinoma 3Urinary Bladder Neoplasms 2Multiple Myeloma 2

Interventions

Dexamethasone 20Melphalan 13Thalidomide 10Bortezomib 10Lenalidomide 8Cyclophosphamide 8Prednisone 6Filgrastim 6Doxorubicin 6Vincristine 5Epoetin Alfa 5pomalidomide 3Zoledronic Acid 3Peripheral Blood Stem Cell Transplantation 3Idarubicin 3carfilzomib 2Vorinostat 2Radiotherapy 2Interferon-alpha 2Granulocyte Colony-Stimulating Factor 2Early Intervention, Educational 2Darbepoetin alfa 2Carmustine 2Calcium Dobesilate 2Busulfan 2valspodar 1sargramostim 1oblimersen 1liposomal doxorubicin 1isatuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms, Plasma Cell × Drug Therapy × Clear all
NCT00416897 2013-08-26

Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure

National Cancer Institute (NCI)

Phase 3 Completed
280 enrolled
Plasma cell

Multiple Myeloma, Renal Insufficiency, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡